DermTech
(OTC) DMTK
DermTech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$15.66M
Net Income (TTM)
$89.63M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
DMTK News
DMTK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout DermTech
Industry
Biotechnology
Sector
Health CareEmployees
208
CEO
Bret Christensen, MBA
Website
www.dermtech.comHeadquarters
La Jolla, CA 92037, US
DMTK Financials
Key Financial Metrics (TTM)
Gross Margin
2%
Operating Margin
-7%
Net Income Margin
-7%
Return on Equity
-1%
Return on Capital
-96%
Return on Assets
-83%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$276.00K
Operating Income
$103.74M
EBITDA
$97.89M
Operating Cash Flow
$76.98M
Capital Expenditure
$902.00K
Free Cash Flow
$77.88M
Cash & ST Invst.
$55.86M
Total Debt
$54.39M
DermTech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.85M
+10.6%
Gross Profit
$713.00K
+307.3%
Gross Margin
18.54%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
206
N/A
Net Income
$20.01M
+36.0%
EBITDA
$19.10M
+37.1%
Quarterly Fundamentals
Net Cash
$14.69M
-129.9%
Accounts Receivable
$2.50M
-32.3%
Inventory
$831.00K
-47.2%
Long Term Debt
$50.46M
-6.1%
Short Term Debt
$3.21M
+73.3%
Return on Assets
-82.74%
N/A
Return on Invested Capital
-95.63%
N/A
Free Cash Flow
$17.12M
+24.9%
Operating Cash Flow
$17.12M
+22.3%